Advertisement

Sports Medicine

, Volume 44, Issue 9, pp 1197–1207 | Cite as

Progressive Resistance Training in Polycystic Ovary Syndrome: Can Pumping Iron Improve Clinical Outcomes?

  • Birinder S. Cheema
  • Lisa Vizza
  • Soji Swaraj
Review Article

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and cause of subfertility in women. The etiology of PCOS has not been fully elucidated; however, insulin resistance has been shown to exacerbate the disease process due to its effect on androgen synthesis. Progressive resistance training (PRT) is an anabolic exercise modality that can improve skeletal muscle size and quality (metabolic capacity), and studies have consistently shown that PRT can increase insulin sensitivity in type 2 diabetes and other cohorts. However, PRT is not currently recommended or routinely prescribed in PCOS. The objective of this article was to provide a rationale for the application of PRT in the management and treatment of PCOS. This will be accomplished by (1) overviewing the pathophysiology of PCOS with emphasis on the etiological role of insulin resistance; (2) summarizing the effectiveness of PRT in treating insulin resistance; (3) presenting evidence that PRT is feasible to prescribe in women with PCOS; and (4) providing general recommendations for PRT to complement existing guidelines for aerobic training in this cohort. We also provide recommendations for future research.

Keywords

Insulin Resistance Polycystic Ovary Syndrome Aerobic Training Progressive Resistance Training Androgen Excess 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Birinder S. Cheema is guarantor of the paper, taking responsibility for the integrity of the work as a whole, from inception to published article. All authors have contributed to the preparation of the manuscript and have approved and read the final article. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. All authors declare they have no competing interests.

References

  1. 1.
    March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reprod. 2010;25(2):544–51.CrossRefGoogle Scholar
  2. 2.
    Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.CrossRefGoogle Scholar
  3. 3.
    Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36.PubMedCrossRefGoogle Scholar
  4. 4.
    Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235–44.PubMedCrossRefGoogle Scholar
  6. 6.
    Gorry A, White DM, Franks S. Infertility in polycystic ovary syndrome. Endocrine. 2006;30(1):27–33.PubMedCrossRefGoogle Scholar
  7. 7.
    Bhattacharya SM, Jha A. Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertil Steril. 2010;94(1):357–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93(7):2421–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. 2006;11(4):613–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279–86.PubMedCrossRefGoogle Scholar
  11. 11.
    Schmidt J, Landin-Wilhelmsen K, Brännström M, et al. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J Clin Endocrinol Metab. 2011;96(12):3794–803.PubMedCrossRefGoogle Scholar
  12. 12.
    de Groot PC, Dekkers OM, Romijn JA, et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(4):495–500.PubMedCrossRefGoogle Scholar
  13. 13.
    Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.PubMedCrossRefGoogle Scholar
  14. 14.
    Chittenden BG, Fullerton G, Maheshwari A, et al. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009;19(3):398–405.PubMedCrossRefGoogle Scholar
  15. 15.
    Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195(6):S65–112.PubMedCrossRefGoogle Scholar
  17. 17.
    Hordern MD, Dunstan DW, Prins JB, et al. Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. J Sci Med Sport. 2012;15(1):25–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Sharman JE, Stowasser M. Australian Association for Exercise and Sports Science position statement on exercise and hypertension. J Sci Med Sport. 2009;12(2):252–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Hayes S, Spence R, Galvao D, et al. Australian Association of Exercise and Sport Science position stand: optimising cancer outcomes through exercise. J Sci Med Sport. 2009;12:428–34.PubMedCrossRefGoogle Scholar
  20. 20.
    Donnelly J, Blair S, Jakicic J, American College of Sports Medicine Position Stand, et al. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459–71.PubMedCrossRefGoogle Scholar
  21. 21.
    Selig SE, Levinger I, Williams AD, et al. Exercise & Sports Science Australia Position Statement on exercise training and chronic heart failure. J Sci Med Sport. 2010;13(3):288–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):e147–67.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Kraemer W, Adams K, Cafarelli E, et al. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2002;34(2):364–80.PubMedCrossRefGoogle Scholar
  24. 24.
    Ciccolo J, Kraemer WJ. Resistance training for the prevention and treatment of chronic disease. Boca Raton: CRC Press; 2013.CrossRefGoogle Scholar
  25. 25.
    Tresierras M, Balady G. Resistance training in the treatment of diabetes and obesity: mechanisms and outcomes. J Cardiopulm Rehabil Prev. 2009;29(2):67–75.PubMedCrossRefGoogle Scholar
  26. 26.
    Strasser B, Schobersberger W. Evidence for resistance training as a treatment therapy in obesity. J Obes 2011. doi: 10.1155/2011/482564.
  27. 27.
    Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome. Sports Med. 2010;40(5):397–415.PubMedCrossRefGoogle Scholar
  28. 28.
    Sigal R, Kenny G, Boulé N, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med. 2007;147:357–69.PubMedCrossRefGoogle Scholar
  29. 29.
    Diamanti-Kandarakis E, Christakou C. Insulin resistance in PCOS. In: Farid N, Diamanti-Kandarakis E, editors. Diagnosis and management of polycystic ovary syndrome. New York: Springer; 2009. p. 35–61.CrossRefGoogle Scholar
  30. 30.
    Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777–84.PubMedCrossRefGoogle Scholar
  31. 31.
    Aubuchon M, Laughbaum N, Poetker A, et al. Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome. Fertil Steril. 2009;91(4):1336–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Bruner B, Chad K, Chizen D. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab. 2006;31(4):384–91.PubMedCrossRefGoogle Scholar
  33. 33.
    Thomson RL, Buckley JD, Lim SS, et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril. 2010;94(5):1812–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Thomson RL, Buckley JD, Noakes M, et al. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(9):3373–80.PubMedCrossRefGoogle Scholar
  35. 35.
    Mahoney D. Lifestyle modification intervention among infertile overweight and obese women with polycystic ovary syndrome. J Am Assoc Nurse Pract 2013. doi: 10.1002/2327-6924.12073.
  36. 36.
    Boyle J, Teede HJ. Polycystic ovary syndrome: an update. Aust Fam Physician. 2012;41(10):752–6.PubMedGoogle Scholar
  37. 37.
    National Institutes of Health. Evidence-based methodology workshop on polycystic ovary syndrome, 3–5 December 2012. Executive summary. Final report. National Institutes of Health; 2012. Available from: https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf.
  38. 38.
    Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol. 2003;60(1):1–17.CrossRefGoogle Scholar
  39. 39.
    Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):707–18.PubMedCrossRefGoogle Scholar
  40. 40.
    Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2007;3(2):103–11.PubMedCrossRefGoogle Scholar
  41. 41.
    Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–59.PubMedCrossRefGoogle Scholar
  42. 42.
    Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–37.PubMedCrossRefGoogle Scholar
  43. 43.
    Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526–32.PubMedCrossRefGoogle Scholar
  44. 44.
    Toprak S, Yonem A, Cakir B, et al. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res. 2001;55(2):65–70.PubMedCrossRefGoogle Scholar
  45. 45.
    Cascella T, Palomba S, De Sio I, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008;23(1):153–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007;92(7):2500–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 2001;16(6):1255–60.PubMedCrossRefGoogle Scholar
  48. 48.
    Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003;79(6):1358–64.PubMedCrossRefGoogle Scholar
  49. 49.
    Hutchison SK, Stepto NK, Harrison CL, et al. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(1):E48–56.PubMedCrossRefGoogle Scholar
  50. 50.
    Amati F, Pennant M, Azuma K, et al. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity. 2012;20(5):1115–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Moran LJ, Ranasinha S, Zoungas S, et al. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod. 2013;28(8):2276–83.PubMedCrossRefGoogle Scholar
  52. 52.
    Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.PubMedCrossRefGoogle Scholar
  53. 53.
    Welt CK, Taylor AE, Fox J, et al. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab. 2005;90(10):5582–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107–17.PubMedCrossRefGoogle Scholar
  55. 55.
    Lovejoy J, Bray G, Bourgeois M, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women: a clinical research center study. Clin Endocrinol Metab. 1996;81(6):2198–203.Google Scholar
  56. 56.
    Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci. 2002;102(2):151–66.PubMedCrossRefGoogle Scholar
  57. 57.
    Corbould A. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Panminerva Med. 2008;50(4):279–94.PubMedGoogle Scholar
  58. 58.
    Dantas WS, Gualano B, Rocha MP, et al. Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue. Scientific World J 2013. doi: 10.1155/2013/178364.
  59. 59.
    Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Dunaif A, Wu X, Lee A, et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001;281(2):E392–9.PubMedGoogle Scholar
  61. 61.
    Skov V, Glintborg D, Knudsen S, et al. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes. 2007;56(9):2349–55.PubMedCrossRefGoogle Scholar
  62. 62.
    Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100(14):8466–71.PubMedCentralPubMedCrossRefGoogle Scholar
  63. 63.
    Mootha VK, Lindgren CM, Eriksson K-F, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73.PubMedCrossRefGoogle Scholar
  64. 64.
    Puder JJ, Varga S, Kraenzlin M, et al. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab. 2005;90(11):6014–21.PubMedCrossRefGoogle Scholar
  65. 65.
    Corbould A, Kim YB, Youngren JF, et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab. 2005;288(5):E1047–54.PubMedCrossRefGoogle Scholar
  66. 66.
    Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style? J Endocrinol Invest. 1998;21(9):589–601.PubMedCrossRefGoogle Scholar
  67. 67.
    Busfield F, Duffy DL, Kesting JB, et al. A genomewide search for type 2 diabetes: susceptibility genes in indigenous Australians. Am J Hum Genet. 2002;70(2):349–57.PubMedCentralPubMedCrossRefGoogle Scholar
  68. 68.
    Sukala W, Page R, Cheema B. Targeting the type 2 diabetes epidemic in Polynesia: historical perspective and rationale for exercise intervention trials. Ethn Dis. 2012;22(2):123–8.PubMedGoogle Scholar
  69. 69.
    Chakravarthy MV, Booth FW. Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol. 2004;96(1):3–10.PubMedCrossRefGoogle Scholar
  70. 70.
    Hutchison S, Teede H, Rachoń D, et al. Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia. 2012;55(5):1424–34.PubMedCrossRefGoogle Scholar
  71. 71.
    Stannard S, Johnson N. Insulin resistance and elevated triglyceride in muscle: more important for survival than ‘thrifty’ genes? J Physiol. 2003;554(3):595–607.PubMedCentralPubMedCrossRefGoogle Scholar
  72. 72.
    Cooney GJ, Thompson AL, Furler SM, et al. Muscle long-chain Acyl CoA Esters and insulin resistance. Ann N Y Acad Sci. 2002;967(1):196–207.PubMedCrossRefGoogle Scholar
  73. 73.
    Amati F, Dube JJ, Alvarez-Carnero E, et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes. 2011;60(10):2588–97.PubMedCentralPubMedCrossRefGoogle Scholar
  74. 74.
    Zierath JR, Krook A, Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia. 2000;43(7):821–35.PubMedCrossRefGoogle Scholar
  75. 75.
    Peppa M, Koliaki C, Nikolopoulos P, et al. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010. doi: 10.1155/2010/527850.
  76. 76.
    Gordon B, Benson A, Bird S, et al. Resistance training improves metabolic health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 2009;83:157–75.PubMedCrossRefGoogle Scholar
  77. 77.
    Ibanez J, Izquierdo M, Arguelles I, et al. Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care. 2005;28:662–7.PubMedCrossRefGoogle Scholar
  78. 78.
    Shaibi G, Cruz M, Ball G, et al. Effects of resistance training on insulin sensitivity in overweight latino adolescent males. Med Sci Sports Exerc. 2006;38(7):1208–15.PubMedCrossRefGoogle Scholar
  79. 79.
    Ishii T, Yamakita T, Sato T, et al. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care. 1998;21(8):1353–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Poehlman E, Dvorak R, DeNino W, et al. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J Clin Endocrinol Metab. 2000;85:2463–8.PubMedGoogle Scholar
  81. 81.
    Hawley J, Lessard S. Exercise training-induced improvements in insulin action. Acta Physiol. 2008;192:127–35.CrossRefGoogle Scholar
  82. 82.
    Holten M, Zacho M, Gaster M, et al. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscles in patients with type 2 diabetes. Diabetes. 2004;53:294–305.PubMedCrossRefGoogle Scholar
  83. 83.
    Jorge MLMP, de Oliveira VN, Resende NM, et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism. 2011;60(9):1244–52.PubMedCrossRefGoogle Scholar
  84. 84.
    Jubrias SA, Esselman PC, Price LB, et al. Large energetic adaptations of elderly muscle to resistance and endurance training. J Appl Physiol. 2001;90(5):1663–70.PubMedGoogle Scholar
  85. 85.
    Moran LJ, Hutchison SK, Norman RJ, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011;(2):CD007506.Google Scholar
  86. 86.
    Harrison CL, Lombard CB, Moran LJ, et al. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011;17(2):171–83.PubMedCrossRefGoogle Scholar
  87. 87.
    Thomson RL, Buckley JD, Brinkworth GD. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature. Obes Rev. 2011;12(5):e202–10.PubMedCrossRefGoogle Scholar
  88. 88.
    Giallauria F, Palomba S, Maresca L, et al. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clin Endocrinol. 2008;69(5):792–8.CrossRefGoogle Scholar
  89. 89.
    Harrison CL, Stepto NK, Hutchison SK, et al. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol. 2012;76(3):351–7.CrossRefGoogle Scholar
  90. 90.
    Palomba S, Giallauria F, Falbo A, et al. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod. 2008;23(3):642–50.PubMedCrossRefGoogle Scholar
  91. 91.
    Randeva HS, Lewandowski KC, Drzewoski J, et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(10):4496–501.PubMedCrossRefGoogle Scholar
  92. 92.
    Brown AJ, Setji TL, Sanders LL, et al. Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. Med Sci Sports Exerc. 2009;41(3):497–504.PubMedCentralPubMedCrossRefGoogle Scholar
  93. 93.
    Stener-Victorin E, Jedel E, Janson PO, et al. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. Am J Physiol Regul Integr Comp Physiol. 2009;297(2):R387–95.PubMedGoogle Scholar
  94. 94.
    Vigorito C, Giallauria F, Palomba S, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(4):1379–84.PubMedCrossRefGoogle Scholar
  95. 95.
    Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32. doi: 10.1186/1745-6215-11-32.PubMedCentralPubMedCrossRefGoogle Scholar
  96. 96.
    Cheema B, Robergs R, Askew C. Exercise physiologists emerge as allied healthcare professionals in the era of non-communicable disease pandemics: a report from Australia, 2006–2012. Sports Med. Epub 25 Mar 2014. http://www.ncbi.nlm.nih.gov/pubmed/24664532.

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.School of Science and HealthUniversity of Western SydneyPenrithAustralia
  2. 2.The National Institute of Complementary MedicineUniversity of Western SydneyPenrithAustralia
  3. 3.Department of EndocrinologyConcord Repatriation General HospitalConcord WestAustralia

Personalised recommendations